Cargando…
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs
Genetic drugs based on nucleic acid biomolecules are a rapidly emerging class of medicines that directly reprogramme the central dogma of biology to prevent and treat disease. However, multiple biological barriers normally impede the intracellular delivery of nucleic acids, necessitating the use of...
Autores principales: | Dilliard, Sean A., Siegwart, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850348/ https://www.ncbi.nlm.nih.gov/pubmed/36691401 http://dx.doi.org/10.1038/s41578-022-00529-7 |
Ejemplares similares
-
Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing
por: Cheng, Qiang, et al.
Publicado: (2020) -
Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang, Linhua, et al.
Publicado: (2015) -
Discovery and in Vivo Evaluation of Novel RGD-Modified Lipid-Polymer Hybrid Nanoparticles for Targeted Drug Delivery
por: Zhao, Yinbo, et al.
Publicado: (2014) -
Hesperidin-Loaded Lipid Polymer Hybrid Nanoparticles for Topical Delivery of Bioactive Drugs
por: Jangde, Rajendra, et al.
Publicado: (2022) -
Preparation and characterization of vinculin-targeted polymer–lipid nanoparticle as intracellular delivery vehicle
por: Wang, Junping, et al.
Publicado: (2013)